These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP). Friedrich N, Alte D, Völzke H, Spilcke-Liss E, Lüdemann J, Lerch MM, Kohlmann T, Nauck M, Wallaschofski H. Growth Horm IGF Res; 2008 Jun; 18(3):228-37. PubMed ID: 17997337 [Abstract] [Full Text] [Related]
3. The association between insulin-like growth factor I and bone turnover markers in the general adult population. Niemann I, Hannemann A, Nauck M, Spielhagen C, Völzke H, Wallaschofski H, Friedrich N. Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936 [Abstract] [Full Text] [Related]
4. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients. Charalampaki P, Hildebrandt G, Schaeffer HJ, Schönau E, Klug N. Exp Clin Endocrinol Diabetes; 1998 Sep; 106(2):130-4. PubMed ID: 9628244 [Abstract] [Full Text] [Related]
5. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice. Bielohuby M, Roemmler J, Manolopoulou J, Johnsen I, Sawitzky M, Schopohl J, Reincke M, Wolf E, Hoeflich A, Bidlingmaier M. Exp Biol Med (Maywood); 2009 Aug; 234(8):1002-9. PubMed ID: 19491373 [Abstract] [Full Text] [Related]
6. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R. Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339 [Abstract] [Full Text] [Related]
7. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM. Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949 [Abstract] [Full Text] [Related]
8. A potentially deleterious role of IGFBP-2 on bone density in aging men and women. Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ, Khosla S. J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989 [Abstract] [Full Text] [Related]
9. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A. Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047 [Abstract] [Full Text] [Related]
12. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K. Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [Abstract] [Full Text] [Related]
19. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children. Gunnell D, Miller LL, Rogers I, Holly JM, ALSPAC Study Team. Pediatrics; 2005 Nov; 116(5):e681-6. PubMed ID: 16263982 [Abstract] [Full Text] [Related]
20. Insulin-like growth factor-1 is a predictor of blood haemoglobin concentration in 70-yr-old subjects. Nilsson-Ehle H, Bengtsson BA, Lindstedt G, Mellström D. Eur J Haematol; 2005 Feb; 74(2):111-6. PubMed ID: 15654900 [Abstract] [Full Text] [Related] Page: [Next] [New Search]